Author(s)

Emad Mohsen Barsoum¹, Fiby Samir Boules¹, May Gamal Ashour², Mohsen Samy Barsoum¹

¹Barsoum Oncology Center (BOC), Cairo, Egypt.
²Radiation Oncology and Nuclear Medicine Department, National Cancer Institute, Cairo University, Cairo, Egypt.

Erdheim-Chester disease (ECD) is a rare non-Langerhans form of histiocytosis characterized by multisystemic involvement. We report a case of a 51-year-old male patient treated with pegylated IFN-α in a monthly schedule with low-dose prednisolone and achieved 34 months of control with minimal side effects.

Erdheim-Chester Disease, Histiocytoses, Non-Langerhans Cell Histiocytoses

Barsoum, E. , Boules, F. , Ashour, M. and Barsoum, M. (2021) Thirty-Four Months Control of Frail Patient with Multisystemic Affection Proved Erdheim Chester Disease: A Case Report. Journal of Cancer Therapy, 12, 689-694. doi: 10.4236/jct.2021.1212060.